Zydus Hospira Oncology Private Limited — Cytarabine Exporter Profile
Indian Pharmaceutical Exporter · #4 for Cytarabine · $498.8K export value · DGFT Verified
Zydus Hospira Oncology Private Limited is the #4 Indian exporter of Cytarabine with $498.8K in export value and 11 verified shipments. Zydus Hospira Oncology Private Limited holds a 4.6% market share in Cytarabine exports across 7 countries. The company exports 5 pharmaceutical products worth $4.7M across 2 therapeutic categories.
Zydus Hospira Oncology Private Limited — Cytarabine Export Profile: Buyers & Destinations
Where Does Zydus Hospira Oncology Private Limited Export Cytarabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $100.0K | 2 | 35.7% |
| UNITED STATES | $50.0K | 1 | 17.9% |
| UNITED STATES OF AMERICA | $50.0K | 1 | 17.9% |
| AUSTRALIA | $41.9K | 2 | 15.0% |
| NORTH KOREA | $15.7K | 1 | 5.6% |
| SOUTH KOREA | $15.7K | 1 | 5.6% |
| BELGIUM | $6.1K | 1 | 2.2% |
| CZECH REPUBLIC | $707 | 2 | 0.3% |
Zydus Hospira Oncology Private Limited exports Cytarabine to 8 countries. The largest destination is CANADA accounting for 35.7% of Zydus Hospira Oncology Private Limited's Cytarabine shipments, followed by UNITED STATES (17.9%) and UNITED STATES OF AMERICA (17.9%). These destinations reflect Zydus Hospira Oncology Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cytarabine from Zydus Hospira Oncology Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PFIZER SERVICE COMPANY BV | CZECH REPUBLIC | $143.3K | 6 |
| XXIZEXXSERXXCE XXMPAXX BV | CZECH REPUBLIC | $136.8K | 5 |
Zydus Hospira Oncology Private Limited supplies Cytarabine to 2 buyers globally. The largest buyer is PFIZER SERVICE COMPANY BV (CZECH REPUBLIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cytarabine Export Value and How Much Does Zydus Hospira Oncology Private Limited Contribute?
India exported $9.8M worth of Cytarabine through 1,825 shipments from 175 suppliers to 110 countries, serving 381 buyers globally. Zydus Hospira Oncology Private Limited contributes $498.8K to this total, accounting for 4.6% of India's Cytarabine exports. Zydus Hospira Oncology Private Limited ships Cytarabine to 8 countries through 2 buyers.
What Is the Average Shipment Value for Zydus Hospira Oncology Private Limited's Cytarabine Exports?
Zydus Hospira Oncology Private Limited's average Cytarabine shipment value is $45.3K per consignment, based on 11 shipments totaling $498.8K. The largest destination is CANADA (35.7% of Zydus Hospira Oncology Private Limited's Cytarabine exports).
How Does Zydus Hospira Oncology Private Limited Compare to Other Indian Cytarabine Exporters?
Zydus Hospira Oncology Private Limited ranks #4 among 175 Indian Cytarabine exporters with a 4.6% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($5.1M), FRESENIUS KABI ONCOLOGY LIMITED ($1.8M), NAPROD LIFE SCIENCES PRIVATE LIMITED ($557.0K). Zydus Hospira Oncology Private Limited processed 11 shipments to 7 destination countries.
What Cytarabine Formulations Does Zydus Hospira Oncology Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CYTARABINE INJ. 2G CA-F000210843 | $100.0K | 2 |
| CYTARABINE INJECTION 2G US-F000206976 | $100.0K | 2 |
| CYTARABINE INJ. 2G AU - F000046298 | $41.9K | 2 |
| CYTARABINE INJ. 2 G KR - F000210842 | $31.4K | 2 |
| CYTARABINE INJ. 100MG UK/MT-F000210807 | $6.1K | 1 |
| CYTARABINE INJ. 2G BR - H000205137 | $602 | 1 |
| CYTARABINE INJ. 100MG BR -H000205135 | $105 | 1 |
Zydus Hospira Oncology Private Limited exports 7 distinct Cytarabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYTARABINE INJ. 2G CA-F000210843 with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Cytarabine to Key Markets
What Zydus Hospira Oncology Private Limited must comply with to export Cytarabine to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Zydus Hospira Oncology Private Limited Compare to Nearest Cytarabine Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | FRESENIUS KABI ONCOLOGY LIMITED | $1.8M | 98 | 13 | $18.5K |
| 3 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $557.0K | 52 | 8 | $10.7K |
| 4 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED ★ | $498.8K | 11 | 7 | $45.3K |
| 5 | CELON LABORATORIES PRIVATE LIMITED | $313.6K | 44 | 11 | $7.1K |
| 6 | RUS MED EXPORTS PVT. LTD. | $311.9K | 16 | 1 | $19.5K |
Zydus Hospira Oncology Private Limited ranks #4 among 175 Indian Cytarabine exporters. Average shipment value of $45.3K compared to the market average of $56.0K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Cytarabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 249 | 13.6% |
| SAHAR AIR | 242 | 13.3% |
| DELHI AIR | 159 | 8.7% |
| AHEMDABAD AIR ACC (INAMD4) | 145 | 7.9% |
| DELHI AIR CARGO ACC (INDEL4) | 144 | 7.9% |
| AHEMDABAD AIR | 142 | 7.8% |
| MUNDRA SEA (INMUN1) | 139 | 7.6% |
| MUNDRA SEA | 111 | 6.1% |
What Other Advanced Oncology Products Does Zydus Hospira Oncology Private Limited Export?
Zydus Hospira Oncology Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Zydus Hospira Oncology Private Limited
Zydus Hospira Oncology Private Limited exports 5 products worth $4.7M. Beyond Cytarabine, top products include Gemcitabine, Oxaliplatin, Irinotecan, Docetaxel. View the complete Zydus Hospira Oncology Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cytarabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cytarabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Hospira Oncology Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 11 individual customs records matching Zydus Hospira Oncology Private Limited exporting Cytarabine, covering 7 formulations to 8 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 110+ countries, 381+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cytarabine Export Data from Zydus Hospira Oncology Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Hospira Oncology Private Limited's Cytarabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Hospira Oncology Private Limited
Full Company Profile →
5 products · $4.7M total trade · 2 categories
Cytarabine Stats
Company Overview
Top Products by Zydus Hospira Oncology Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Hospira Oncology Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cytarabine. For current shipment-level data, contact TransData Nexus.